Wesana Health Holdings Inc.
WSNAF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 4/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 784.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 30.5% | 33.5% |
| R&D Expenses | $0 | $0 | $3 | $0 |
| G&A Expenses | $0 | $3 | $10 | $0 |
| SG&A Expenses | $1 | $3 | $11 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $3 | $14 | $0 |
| Operating Income | -$1 | -$3 | -$14 | -$0 |
| % Margin | – | – | -5,089.4% | -288.7% |
| Other Income/Exp. Net | -$1 | $0 | $7 | $0 |
| Pre-Tax Income | -$2 | -$3 | -$6 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$9 | -$34 | -$0 |
| % Margin | – | – | -12,851.2% | -288.7% |
| EPS | -0.05 | -0.24 | -1.47 | -0.007 |
| % Growth | 79.1% | 83.7% | -21,204.3% | – |
| EPS Diluted | -0.05 | -0.24 | -1.47 | -0.007 |
| Weighted Avg Shares Out | 35 | 34 | 23 | 13 |
| Weighted Avg Shares Out Dil | 35 | 34 | 23 | 13 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | -$6 | -$0 |
| % Margin | – | – | -2,325.7% | -288.7% |